The distribution and prevalence of the classical APS markers (LAC and IgG and IgM aCL and aβ2GPI) as well as non-criteria APS biomarkers (aPS/PT, IgA aCL and aβ2GPI) in the first and second determination are shown in Table 2. This evidence concerns the gene CD79A and autoimmune polyendocrinopathy.